

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.84970548 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.83521585 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.69582062 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.69582062 |
| 5 | positive thymic T cell selection (GO:0045059) | 4.30514238 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.03271670 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.00288920 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.99571261 |
| 9 | substrate-dependent cell migration (GO:0006929) | 3.95994291 |
| 10 | leukocyte aggregation (GO:0070486) | 3.89179700 |
| 11 | morphogenesis of an endothelium (GO:0003159) | 3.88519961 |
| 12 | endothelial tube morphogenesis (GO:0061154) | 3.88519961 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 3.84304095 |
| 14 | negative thymic T cell selection (GO:0045060) | 3.77049436 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74804781 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.72953861 |
| 17 | negative T cell selection (GO:0043383) | 3.70148463 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65084157 |
| 19 | regulation of T cell tolerance induction (GO:0002664) | 3.63315535 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 3.61552612 |
| 21 | thymic T cell selection (GO:0045061) | 3.57103696 |
| 22 | negative regulation of protein activation cascade (GO:2000258) | 3.44653478 |
| 23 | tolerance induction (GO:0002507) | 3.41921127 |
| 24 | hepatocyte apoptotic process (GO:0097284) | 3.41638635 |
| 25 | negative regulation of complement activation (GO:0045916) | 3.40457437 |
| 26 | lymph vessel development (GO:0001945) | 3.32286548 |
| 27 | positive T cell selection (GO:0043368) | 3.31649656 |
| 28 | positive regulation of tolerance induction (GO:0002645) | 3.25146559 |
| 29 | cellular extravasation (GO:0045123) | 3.23595582 |
| 30 | T cell selection (GO:0045058) | 3.21333195 |
| 31 | response to interleukin-15 (GO:0070672) | 3.19059858 |
| 32 | cellular response to zinc ion (GO:0071294) | 3.14894835 |
| 33 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.14544663 |
| 34 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.13942849 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.12664710 |
| 36 | cell proliferation involved in metanephros development (GO:0072203) | 3.11900781 |
| 37 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.06554934 |
| 38 | regulation of complement activation (GO:0030449) | 3.01287808 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.01085715 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01085715 |
| 41 | regulation of tolerance induction (GO:0002643) | 2.96751313 |
| 42 | intestinal cholesterol absorption (GO:0030299) | 2.96399893 |
| 43 | regulation of protein activation cascade (GO:2000257) | 2.94151596 |
| 44 | T cell costimulation (GO:0031295) | 2.91183945 |
| 45 | leukocyte cell-cell adhesion (GO:0007159) | 2.90508424 |
| 46 | negative regulation of protein autophosphorylation (GO:0031953) | 2.89252294 |
| 47 | negative regulation of humoral immune response (GO:0002921) | 2.88399685 |
| 48 | cellular response to interleukin-15 (GO:0071350) | 2.88055909 |
| 49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86800243 |
| 50 | negative regulation of phagocytosis (GO:0050765) | 2.85838256 |
| 51 | lymphocyte costimulation (GO:0031294) | 2.84024050 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.83692909 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82582333 |
| 54 | positive regulation of histone deacetylation (GO:0031065) | 2.82517829 |
| 55 | sulfation (GO:0051923) | 2.79802300 |
| 56 | cell proliferation involved in kidney development (GO:0072111) | 2.79395249 |
| 57 | establishment of endothelial barrier (GO:0061028) | 2.76768064 |
| 58 | regulation of glomerulus development (GO:0090192) | 2.74447990 |
| 59 | membrane repolarization during action potential (GO:0086011) | 2.73829776 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72900119 |
| 61 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.72173353 |
| 62 | positive regulation of lamellipodium assembly (GO:0010592) | 2.70968167 |
| 63 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.70842067 |
| 64 | cellular anion homeostasis (GO:0030002) | 2.70461819 |
| 65 | regulation of fibrinolysis (GO:0051917) | 2.69210725 |
| 66 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.66228919 |
| 67 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.66117803 |
| 68 | positive regulation of fatty acid oxidation (GO:0046321) | 2.65861144 |
| 69 | glomerular basement membrane development (GO:0032836) | 2.65331431 |
| 70 | germ cell migration (GO:0008354) | 2.64176362 |
| 71 | T cell migration (GO:0072678) | 2.61042692 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.60662295 |
| 73 | lymphangiogenesis (GO:0001946) | 2.60637549 |
| 74 | natural killer cell differentiation (GO:0001779) | 2.59972145 |
| 75 | growth hormone receptor signaling pathway (GO:0060396) | 2.56238631 |
| 76 | B cell proliferation (GO:0042100) | 2.55346975 |
| 77 | interferon-gamma production (GO:0032609) | 2.55165379 |
| 78 | neutrophil activation (GO:0042119) | 2.54763072 |
| 79 | regulation of hippo signaling (GO:0035330) | 2.53858024 |
| 80 | endocardial cushion development (GO:0003197) | 2.53794257 |
| 81 | response to laminar fluid shear stress (GO:0034616) | 2.53317486 |
| 82 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51928934 |
| 83 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51928934 |
| 84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51928934 |
| 85 | modulation by symbiont of host immune response (GO:0052553) | 2.51928934 |
| 86 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51928934 |
| 87 | modulation by symbiont of host defense response (GO:0052031) | 2.51928934 |
| 88 | cell adhesion mediated by integrin (GO:0033627) | 2.50804490 |
| 89 | surfactant homeostasis (GO:0043129) | 2.50571157 |
| 90 | negative regulation of B cell proliferation (GO:0030889) | 2.50462635 |
| 91 | positive regulation of interleukin-2 production (GO:0032743) | 2.50223325 |
| 92 | nephron epithelium morphogenesis (GO:0072088) | 2.49967402 |
| 93 | nephron tubule morphogenesis (GO:0072078) | 2.49967402 |
| 94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49957487 |
| 95 | regulation of B cell proliferation (GO:0030888) | 2.49772798 |
| 96 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.49252957 |
| 97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.47993500 |
| 98 | positive regulation of macrophage differentiation (GO:0045651) | 2.47612794 |
| 99 | response to muramyl dipeptide (GO:0032495) | 2.47502886 |
| 100 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.47255762 |
| 101 | diacylglycerol metabolic process (GO:0046339) | 2.46370995 |
| 102 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.45385602 |
| 103 | positive regulation of B cell differentiation (GO:0045579) | 2.44376738 |
| 104 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.44310669 |
| 105 | neutrophil activation involved in immune response (GO:0002283) | 2.43937355 |
| 106 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43753484 |
| 107 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.43389181 |
| 108 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.42018130 |
| 109 | chemical homeostasis within a tissue (GO:0048875) | 2.41138551 |
| 110 | angiogenesis involved in wound healing (GO:0060055) | 2.39943890 |
| 111 | intestinal absorption (GO:0050892) | 2.39932803 |
| 112 | regulation of response to interferon-gamma (GO:0060330) | 2.39012195 |
| 113 | positive regulation of lamellipodium organization (GO:1902745) | 2.38638573 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 2.38043480 |
| 115 | regulation of extracellular matrix disassembly (GO:0010715) | 2.37910867 |
| 116 | plasma lipoprotein particle assembly (GO:0034377) | 2.36685535 |
| 117 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.35720678 |
| 118 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.34832624 |
| 119 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.34527612 |
| 120 | regulation of macrophage cytokine production (GO:0010935) | 2.34352381 |
| 121 | lung lobe morphogenesis (GO:0060463) | 2.33786812 |
| 122 | regulation of endothelial cell differentiation (GO:0045601) | 2.33351246 |
| 123 | microglial cell activation (GO:0001774) | 2.33237893 |
| 124 | T cell receptor signaling pathway (GO:0050852) | 2.33156316 |
| 125 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.32702290 |
| 126 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.32388204 |
| 127 | myeloid dendritic cell activation (GO:0001773) | 2.31860216 |
| 128 | positive regulation of interferon-alpha production (GO:0032727) | 2.31748046 |
| 129 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.31593951 |
| 130 | positive regulation of isotype switching (GO:0045830) | 2.30375930 |
| 131 | glomerular visceral epithelial cell development (GO:0072015) | 2.30257707 |
| 132 | regulation of interferon-alpha production (GO:0032647) | 2.30071977 |
| 133 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.29684279 |
| 134 | transepithelial transport (GO:0070633) | 2.29666039 |
| 135 | apoptotic cell clearance (GO:0043277) | 2.29486733 |
| 136 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.29429811 |
| 137 | patterning of blood vessels (GO:0001569) | 2.29177607 |
| 138 | Notch signaling involved in heart development (GO:0061314) | 2.27336984 |
| 139 | granulocyte activation (GO:0036230) | 2.26927883 |
| 140 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.26027673 |
| 141 | natural killer cell activation (GO:0030101) | 2.25839502 |
| 142 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.25515339 |
| 143 | positive regulation of B cell proliferation (GO:0030890) | 2.23400542 |
| 144 | positive regulation of astrocyte differentiation (GO:0048711) | 2.23331882 |
| 145 | myeloid dendritic cell differentiation (GO:0043011) | 2.23038265 |
| 146 | response to type I interferon (GO:0034340) | 2.22936292 |
| 147 | lipoprotein metabolic process (GO:0042157) | 2.20912428 |
| 148 | regulation of regulatory T cell differentiation (GO:0045589) | 2.20074960 |
| 149 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.18439787 |
| 150 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.17938695 |
| 151 | flavonoid metabolic process (GO:0009812) | 2.16633842 |
| 152 | high-density lipoprotein particle remodeling (GO:0034375) | 2.15382891 |
| 153 | phosphate ion homeostasis (GO:0055062) | 2.14419957 |
| 154 | trivalent inorganic anion homeostasis (GO:0072506) | 2.14419957 |
| 155 | SMAD protein signal transduction (GO:0060395) | 2.13983348 |
| 156 | negative regulation of metanephros development (GO:0072217) | 2.13780659 |
| 157 | interkinetic nuclear migration (GO:0022027) | 2.13767788 |
| 158 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.13369755 |
| 159 | blood coagulation, intrinsic pathway (GO:0007597) | 2.13347641 |
| 160 | regulation of cholesterol homeostasis (GO:2000188) | 2.12896678 |
| 161 | positive regulation of male gonad development (GO:2000020) | 2.12601864 |
| 162 | positive regulation of metanephros development (GO:0072216) | 2.11499772 |
| 163 | regulation of humoral immune response (GO:0002920) | 2.10479812 |
| 164 | plasma lipoprotein particle remodeling (GO:0034369) | 2.10276523 |
| 165 | protein-lipid complex remodeling (GO:0034368) | 2.10276523 |
| 166 | macromolecular complex remodeling (GO:0034367) | 2.10276523 |
| 167 | lung vasculature development (GO:0060426) | 2.09633930 |
| 168 | activated T cell proliferation (GO:0050798) | 2.09080576 |
| 169 | regulation of metanephros development (GO:0072215) | 2.08996107 |
| 170 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.08629444 |
| 171 | interferon-gamma secretion (GO:0072643) | 2.08624809 |
| 172 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.08423838 |
| 173 | phospholipid homeostasis (GO:0055091) | 2.08084580 |
| 174 | reverse cholesterol transport (GO:0043691) | 2.07182062 |
| 175 | negative regulation of fatty acid transport (GO:2000192) | 2.05654291 |
| 176 | positive regulation of blood coagulation (GO:0030194) | 2.04908413 |
| 177 | positive regulation of hemostasis (GO:1900048) | 2.04908413 |
| 178 | regulation of cholesterol storage (GO:0010885) | 2.04162704 |
| 179 | regulation of alkaline phosphatase activity (GO:0010692) | 2.02807692 |
| 180 | mesonephros development (GO:0001823) | 2.02184040 |
| 181 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.01462139 |
| 182 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.01462139 |
| 183 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.01418309 |
| 184 | low-density lipoprotein particle clearance (GO:0034383) | 2.00951859 |
| 185 | plasma lipoprotein particle organization (GO:0071827) | 2.00771221 |
| 186 | T cell mediated immunity (GO:0002456) | 1.99861470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.04032773 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.87781753 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.29528928 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.72675838 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.53726198 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89550798 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.86738480 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82737465 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.74097149 |
| 10 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70335249 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64224232 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.61183912 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53087887 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48699477 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.43570684 |
| 16 | * MYB_26560356_Chip-Seq_TH2_Human | 2.41688126 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41531163 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37331626 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.36054793 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31065637 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30750852 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29997072 |
| 23 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21469439 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19394476 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10217893 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.08464045 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06433932 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.05928298 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01085222 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98400260 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98369653 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.94249581 |
| 33 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.92584364 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85520611 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84774730 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83987069 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82478286 |
| 38 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80538781 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.79882834 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79096760 |
| 41 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79026751 |
| 42 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77706956 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73621748 |
| 44 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71803812 |
| 45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70338557 |
| 46 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.67929319 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66996019 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64653618 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62939399 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61969933 |
| 51 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57663188 |
| 52 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.56034601 |
| 53 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55375978 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.55259886 |
| 55 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.54932947 |
| 56 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.54865444 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53930625 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53811975 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53094240 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49553025 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49431739 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47682222 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45755011 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44579983 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43365354 |
| 66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42899309 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42007180 |
| 68 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41096329 |
| 69 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40909200 |
| 70 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39802911 |
| 71 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39290866 |
| 72 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38704843 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36688573 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36688573 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33893550 |
| 76 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31978133 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31972316 |
| 78 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31386181 |
| 79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31023341 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30815813 |
| 81 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.29703886 |
| 82 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29385051 |
| 83 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29016458 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28866848 |
| 85 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27967604 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 1.27829612 |
| 87 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27323743 |
| 88 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27314202 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26352493 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26289025 |
| 91 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.26072459 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24609130 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24496025 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23782756 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23769833 |
| 96 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23391148 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21992423 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21404101 |
| 99 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.20572837 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18531122 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17816004 |
| 102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15227720 |
| 103 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14873949 |
| 104 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.13805443 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13157701 |
| 106 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11593659 |
| 107 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.11061381 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10972361 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10391228 |
| 110 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10356917 |
| 111 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09998753 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09571438 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08859425 |
| 114 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07775751 |
| 115 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07095701 |
| 116 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06431718 |
| 117 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05729918 |
| 118 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05503752 |
| 119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04241165 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04069846 |
| 121 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03495809 |
| 122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02543819 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01973326 |
| 124 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01448957 |
| 125 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99667382 |
| 126 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98736679 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98656272 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97592635 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97524510 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97015950 |
| 131 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96017081 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95972375 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95972375 |
| 134 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95910422 |
| 135 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95775741 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95699545 |
| 137 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.95095282 |
| 138 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.94637652 |
| 139 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.94637652 |
| 140 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94596573 |
| 141 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93397705 |
| 142 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93308310 |
| 143 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93308310 |
| 144 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92800955 |
| 145 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92469870 |
| 146 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92389097 |
| 147 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92297804 |
| 148 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92167372 |
| 149 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92040089 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91983898 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91859336 |
| 152 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91048909 |
| 153 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90655164 |
| 154 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.89893623 |
| 155 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89850620 |
| 156 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89649341 |
| 157 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89450927 |
| 158 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88073270 |
| 159 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.88056366 |
| 160 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87555376 |
| 161 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86494916 |
| 162 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85372032 |
| 163 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84878868 |
| 164 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.83933184 |
| 165 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83671584 |
| 166 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.83484146 |
| 167 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83461813 |
| 168 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82911975 |
| 169 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82815687 |
| 170 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81076128 |
| 171 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80940432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.20611071 |
| 2 | MP0010368_abnormal_lymphatic_system | 2.88198610 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 2.83851879 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.79993049 |
| 5 | MP0003303_peritoneal_inflammation | 2.73782685 |
| 6 | MP0005360_urolithiasis | 2.66274139 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.58990391 |
| 8 | MP0001790_abnormal_immune_system | 2.56224267 |
| 9 | MP0005387_immune_system_phenotype | 2.56224267 |
| 10 | MP0000685_abnormal_immune_system | 2.52020970 |
| 11 | MP0001800_abnormal_humoral_immune | 2.46417842 |
| 12 | MP0003724_increased_susceptibility_to | 2.41521523 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.38572017 |
| 14 | MP0005671_abnormal_response_to | 2.28942774 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.27550544 |
| 16 | MP0003195_calcinosis | 2.16281765 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.14598465 |
| 18 | MP0009785_altered_susceptibility_to | 2.11653608 |
| 19 | MP0005377_hearing/vestibular/ear_phenot | 2.08003192 |
| 20 | MP0003878_abnormal_ear_physiology | 2.08003192 |
| 21 | MP0001958_emphysema | 2.07803790 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.06923902 |
| 23 | MP0006054_spinal_hemorrhage | 2.05965508 |
| 24 | MP0003436_decreased_susceptibility_to | 2.02798930 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.02326045 |
| 26 | MP0003252_abnormal_bile_duct | 2.01677684 |
| 27 | MP0003279_aneurysm | 1.97996848 |
| 28 | * MP0002420_abnormal_adaptive_immunity | 1.95590685 |
| 29 | * MP0001819_abnormal_immune_cell | 1.92339340 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.91577788 |
| 31 | MP0001873_stomach_inflammation | 1.91379128 |
| 32 | MP0005409_darkened_coat_color | 1.90384637 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.89737937 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.89098422 |
| 35 | MP0002723_abnormal_immune_serum | 1.88343194 |
| 36 | MP0002006_tumorigenesis | 1.87725183 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.83265609 |
| 38 | MP0005275_abnormal_skin_tensile | 1.79992567 |
| 39 | MP0002933_joint_inflammation | 1.77773226 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.77289204 |
| 41 | MP0009278_abnormal_bone_marrow | 1.77187867 |
| 42 | MP0002405_respiratory_system_inflammati | 1.77075979 |
| 43 | MP0005365_abnormal_bile_salt | 1.72469936 |
| 44 | MP0002398_abnormal_bone_marrow | 1.70876217 |
| 45 | MP0005025_abnormal_response_to | 1.70480473 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.68059316 |
| 47 | MP0004947_skin_inflammation | 1.67759912 |
| 48 | MP0002419_abnormal_innate_immunity | 1.66453903 |
| 49 | MP0003091_abnormal_cell_migration | 1.64519496 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.58947704 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.57510650 |
| 52 | * MP0000716_abnormal_immune_system | 1.56249874 |
| 53 | MP0005670_abnormal_white_adipose | 1.52041267 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.49974433 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.49571721 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.49017294 |
| 57 | MP0005023_abnormal_wound_healing | 1.49014564 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.48431430 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.45357638 |
| 60 | MP0004272_abnormal_basement_membrane | 1.43928899 |
| 61 | MP0004510_myositis | 1.43224196 |
| 62 | MP0001853_heart_inflammation | 1.42038639 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.40625182 |
| 64 | MP0003448_altered_tumor_morphology | 1.40597222 |
| 65 | MP0002928_abnormal_bile_duct | 1.38602724 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.37031283 |
| 67 | * MP0000689_abnormal_spleen_morphology | 1.35052945 |
| 68 | MP0003828_pulmonary_edema | 1.35046084 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.32569782 |
| 70 | MP0003011_delayed_dark_adaptation | 1.32353510 |
| 71 | MP0002132_abnormal_respiratory_system | 1.31494002 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.30570327 |
| 73 | MP0003122_maternal_imprinting | 1.30511220 |
| 74 | MP0009384_cardiac_valve_regurgitation | 1.30040558 |
| 75 | * MP0002722_abnormal_immune_system | 1.29450667 |
| 76 | MP0000858_altered_metastatic_potential | 1.28657732 |
| 77 | * MP0002429_abnormal_blood_cell | 1.26258522 |
| 78 | MP0004885_abnormal_endolymph | 1.24104288 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.22641626 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.22165410 |
| 81 | MP0000767_abnormal_smooth_muscle | 1.22139942 |
| 82 | MP0003183_abnormal_peptide_metabolism | 1.20871512 |
| 83 | MP0003045_fibrosis | 1.20861876 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.20632058 |
| 85 | MP0004130_abnormal_muscle_cell | 1.19828100 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 1.19458654 |
| 87 | MP0001545_abnormal_hematopoietic_system | 1.19458654 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.18961788 |
| 89 | MP0003866_abnormal_defecation | 1.18750103 |
| 90 | MP0005503_abnormal_tendon_morphology | 1.16533546 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.12026299 |
| 92 | MP0006138_congestive_heart_failure | 1.08707156 |
| 93 | MP0001851_eye_inflammation | 1.08350764 |
| 94 | MP0002060_abnormal_skin_morphology | 1.05264742 |
| 95 | MP0000013_abnormal_adipose_tissue | 1.05226500 |
| 96 | MP0005595_abnormal_vascular_smooth | 1.04837282 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 1.03927112 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 1.03327719 |
| 99 | MP0001756_abnormal_urination | 1.02465679 |
| 100 | MP0003879_abnormal_hair_cell | 1.01676399 |
| 101 | MP0000343_altered_response_to | 1.01654352 |
| 102 | MP0003950_abnormal_plasma_membrane | 0.99288046 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.99174277 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.98574726 |
| 105 | MP0005464_abnormal_platelet_physiology | 0.97945784 |
| 106 | MP0004019_abnormal_vitamin_homeostasis | 0.97618133 |
| 107 | MP0002133_abnormal_respiratory_system | 0.97551543 |
| 108 | MP0005388_respiratory_system_phenotype | 0.97551543 |
| 109 | MP0002089_abnormal_postnatal_growth/wei | 0.96093783 |
| 110 | MP0005390_skeleton_phenotype | 0.95843061 |
| 111 | MP0000249_abnormal_blood_vessel | 0.95227206 |
| 112 | MP0002909_abnormal_adrenal_gland | 0.92006932 |
| 113 | MP0002009_preneoplasia | 0.91797858 |
| 114 | MP0004484_altered_response_of | 0.90333738 |
| 115 | MP0006082_CNS_inflammation | 0.88969995 |
| 116 | MP0000490_abnormal_crypts_of | 0.87541974 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.86265326 |
| 118 | MP0009115_abnormal_fat_cell | 0.85011971 |
| 119 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84399503 |
| 120 | MP0009840_abnormal_foam_cell | 0.84129506 |
| 121 | MP0004381_abnormal_hair_follicle | 0.83901659 |
| 122 | MP0002118_abnormal_lipid_homeostasis | 0.82737324 |
| 123 | MP0003136_yellow_coat_color | 0.82445828 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.82301998 |
| 125 | MP0003942_abnormal_urinary_system | 0.81459282 |
| 126 | MP0003795_abnormal_bone_structure | 0.80845800 |
| 127 | MP0002135_abnormal_kidney_morphology | 0.80766987 |
| 128 | MP0002282_abnormal_trachea_morphology | 0.79902447 |
| 129 | MP0002925_abnormal_cardiovascular_devel | 0.78769824 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.78667958 |
| 131 | MP0003868_abnormal_feces_composition | 0.78628204 |
| 132 | MP0004883_abnormal_blood_vessel | 0.78578158 |
| 133 | MP0002128_abnormal_blood_circulation | 0.78235419 |
| 134 | MP0005164_abnormal_response_to | 0.77531959 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.76943537 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.76583522 |
| 137 | MP0000566_synostosis | 0.75566455 |
| 138 | MP0005408_hypopigmentation | 0.75431618 |
| 139 | MP0000733_abnormal_muscle_development | 0.75308576 |
| 140 | MP0000534_abnormal_ureter_morphology | 0.74636961 |
| 141 | MP0001501_abnormal_sleep_pattern | 0.74280483 |
| 142 | MP0009764_decreased_sensitivity_to | 0.73676199 |
| 143 | MP0002168_other_aberrant_phenotype | 0.73352697 |
| 144 | MP0005166_decreased_susceptibility_to | 0.71150029 |
| 145 | MP0001243_abnormal_dermal_layer | 0.70849393 |
| 146 | MP0008469_abnormal_protein_level | 0.69845914 |
| 147 | MP0003943_abnormal_hepatobiliary_system | 0.68234399 |
| 148 | MP0001614_abnormal_blood_vessel | 0.67216382 |
| 149 | MP0002254_reproductive_system_inflammat | 0.66407493 |
| 150 | MP0005623_abnormal_meninges_morphology | 0.65626470 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.65461543 |
| 152 | MP0001663_abnormal_digestive_system | 0.64797593 |
| 153 | MP0002019_abnormal_tumor_incidence | 0.64734324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.47008953 |
| 2 | Abnormality of the nasal septum (HP:0000419) | 4.17633753 |
| 3 | Agammaglobulinemia (HP:0004432) | 3.95148539 |
| 4 | Recurrent bronchitis (HP:0002837) | 3.91070772 |
| 5 | Cellulitis (HP:0100658) | 3.68330402 |
| 6 | Aortic aneurysm (HP:0004942) | 3.58468346 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.38823187 |
| 8 | Optic neuritis (HP:0100653) | 3.31049327 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.31049327 |
| 10 | Interstitial pulmonary disease (HP:0006530) | 3.28986760 |
| 11 | Hematochezia (HP:0002573) | 3.24296456 |
| 12 | Aortic dissection (HP:0002647) | 3.17078433 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.13494581 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 3.11864922 |
| 15 | Joint hemorrhage (HP:0005261) | 3.02951627 |
| 16 | Spontaneous hematomas (HP:0007420) | 3.02073369 |
| 17 | Verrucae (HP:0200043) | 3.01707628 |
| 18 | Papilloma (HP:0012740) | 3.01707628 |
| 19 | Recurrent viral infections (HP:0004429) | 3.01442086 |
| 20 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.98069771 |
| 21 | Glomerulonephritis (HP:0000099) | 2.98007303 |
| 22 | Recurrent fungal infections (HP:0002841) | 2.97545633 |
| 23 | Pigmentary retinal degeneration (HP:0001146) | 2.96569090 |
| 24 | Cerebral aneurysm (HP:0004944) | 2.95912104 |
| 25 | Emphysema (HP:0002097) | 2.95452381 |
| 26 | Small epiphyses (HP:0010585) | 2.95277143 |
| 27 | Colitis (HP:0002583) | 2.88394057 |
| 28 | Protrusio acetabuli (HP:0003179) | 2.87908988 |
| 29 | IgM deficiency (HP:0002850) | 2.87197943 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.87051525 |
| 31 | T lymphocytopenia (HP:0005403) | 2.82327616 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.81527739 |
| 33 | Lymphopenia (HP:0001888) | 2.80954363 |
| 34 | Chronic otitis media (HP:0000389) | 2.74610464 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74087830 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.73340729 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.73277091 |
| 38 | Meningitis (HP:0001287) | 2.71702079 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 2.70589628 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.70241169 |
| 41 | Dilatation of the ascending aorta (HP:0005111) | 2.68027718 |
| 42 | Complement deficiency (HP:0004431) | 2.67131807 |
| 43 | Vascular tortuosity (HP:0004948) | 2.63282565 |
| 44 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.59729371 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.59258849 |
| 46 | Myositis (HP:0100614) | 2.55494479 |
| 47 | Vasculitis (HP:0002633) | 2.54229511 |
| 48 | Osteomyelitis (HP:0002754) | 2.53698429 |
| 49 | Arthropathy (HP:0003040) | 2.52729847 |
| 50 | Decreased circulating renin level (HP:0003351) | 2.51382903 |
| 51 | IgA deficiency (HP:0002720) | 2.50794331 |
| 52 | Genetic anticipation (HP:0003743) | 2.47546703 |
| 53 | Premature rupture of membranes (HP:0001788) | 2.43851564 |
| 54 | Chronic sinusitis (HP:0011109) | 2.42653937 |
| 55 | Vascular calcification (HP:0004934) | 2.42495859 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.41454483 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.40433527 |
| 58 | Abnormality of the frontal sinuses (HP:0002687) | 2.38663178 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38219539 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.37900648 |
| 61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.37667467 |
| 62 | Increased density of long bones (HP:0006392) | 2.37446325 |
| 63 | Abnormality of B cell number (HP:0010975) | 2.37134568 |
| 64 | B lymphocytopenia (HP:0010976) | 2.37134568 |
| 65 | Potter facies (HP:0002009) | 2.36809840 |
| 66 | Facial shape deformation (HP:0011334) | 2.36809840 |
| 67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36658169 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.36658169 |
| 69 | Arterial tortuosity (HP:0005116) | 2.35864390 |
| 70 | Epiphyseal dysplasia (HP:0002656) | 2.35651567 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.34920250 |
| 72 | Thyroiditis (HP:0100646) | 2.34711403 |
| 73 | Subacute progressive viral hepatitis (HP:0006572) | 2.33882377 |
| 74 | Spondylolisthesis (HP:0003302) | 2.33720035 |
| 75 | Prolonged partial thromboplastin time (HP:0003645) | 2.33068197 |
| 76 | Pustule (HP:0200039) | 2.32627505 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 2.32555393 |
| 78 | Ulnar bowing (HP:0003031) | 2.29773602 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 2.28895089 |
| 80 | Abnormality of T cells (HP:0002843) | 2.28800785 |
| 81 | Short femoral neck (HP:0100864) | 2.28256452 |
| 82 | Periodontitis (HP:0000704) | 2.26473691 |
| 83 | Abnormality of the peritoneum (HP:0002585) | 2.26435356 |
| 84 | Nephritis (HP:0000123) | 2.24564100 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.24522628 |
| 86 | Mitral valve prolapse (HP:0001634) | 2.24155434 |
| 87 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.22608713 |
| 88 | Short 4th metacarpal (HP:0010044) | 2.22608713 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.22241739 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.22241739 |
| 91 | Abnormality of the fingertips (HP:0001211) | 2.22042246 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.21743120 |
| 93 | Clumsiness (HP:0002312) | 2.21507934 |
| 94 | Bronchitis (HP:0012387) | 2.21222592 |
| 95 | Mitral stenosis (HP:0001718) | 2.20825952 |
| 96 | Broad metatarsal (HP:0001783) | 2.17731915 |
| 97 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.16090539 |
| 98 | Stomach cancer (HP:0012126) | 2.15828608 |
| 99 | Eosinophilia (HP:0001880) | 2.15772102 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 2.15586050 |
| 101 | Menorrhagia (HP:0000132) | 2.14976439 |
| 102 | Nasal polyposis (HP:0100582) | 2.14446688 |
| 103 | Abnormality of the wing of the ilium (HP:0011867) | 2.14269967 |
| 104 | Vitreoretinal degeneration (HP:0000655) | 2.13430421 |
| 105 | Shallow orbits (HP:0000586) | 2.12056184 |
| 106 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.11531930 |
| 107 | Abnormality of the common coagulation pathway (HP:0010990) | 2.11530306 |
| 108 | Restrictive lung disease (HP:0002091) | 2.11405678 |
| 109 | Xanthomatosis (HP:0000991) | 2.10950440 |
| 110 | Pulmonary embolism (HP:0002204) | 2.09807475 |
| 111 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.08528079 |
| 112 | Atrophic scars (HP:0001075) | 2.08078864 |
| 113 | Portal hypertension (HP:0001409) | 2.07609352 |
| 114 | Metabolic alkalosis (HP:0200114) | 2.06077754 |
| 115 | Joint swelling (HP:0001386) | 2.05845580 |
| 116 | Epidermoid cyst (HP:0200040) | 2.05505391 |
| 117 | Striae distensae (HP:0001065) | 2.04180564 |
| 118 | Recurrent pneumonia (HP:0006532) | 2.03097485 |
| 119 | Viral hepatitis (HP:0006562) | 2.02129843 |
| 120 | Increased corneal curvature (HP:0100692) | 2.00989464 |
| 121 | Keratoconus (HP:0000563) | 2.00989464 |
| 122 | Bronchomalacia (HP:0002780) | 2.00856667 |
| 123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.99967857 |
| 124 | Sepsis (HP:0100806) | 1.99367723 |
| 125 | Gingival bleeding (HP:0000225) | 1.98789336 |
| 126 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.98689198 |
| 127 | True hermaphroditism (HP:0010459) | 1.98647876 |
| 128 | Absent frontal sinuses (HP:0002688) | 1.97204420 |
| 129 | Arterial thrombosis (HP:0004420) | 1.95741406 |
| 130 | Gingivitis (HP:0000230) | 1.95429493 |
| 131 | Sex reversal (HP:0012245) | 1.95254170 |
| 132 | Abnormal sex determination (HP:0012244) | 1.95254170 |
| 133 | Orchitis (HP:0100796) | 1.95100702 |
| 134 | Skin ulcer (HP:0200042) | 1.95082700 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.95026926 |
| 136 | Abnormality of complement system (HP:0005339) | 1.94380455 |
| 137 | Persistence of primary teeth (HP:0006335) | 1.93954682 |
| 138 | Esophageal varix (HP:0002040) | 1.93478804 |
| 139 | Adactyly (HP:0009776) | 1.93059063 |
| 140 | Bicuspid aortic valve (HP:0001647) | 1.92585714 |
| 141 | Hemoptysis (HP:0002105) | 1.92296124 |
| 142 | Periauricular skin pits (HP:0100277) | 1.92267186 |
| 143 | Preauricular pit (HP:0004467) | 1.92267186 |
| 144 | Toxemia of pregnancy (HP:0100603) | 1.91798398 |
| 145 | Pulmonary infiltrates (HP:0002113) | 1.91464473 |
| 146 | IgG deficiency (HP:0004315) | 1.90858104 |
| 147 | Polycythemia (HP:0001901) | 1.90686494 |
| 148 | Peritonitis (HP:0002586) | 1.90486029 |
| 149 | Hypoplasia of the ulna (HP:0003022) | 1.88752634 |
| 150 | Ankle contracture (HP:0006466) | 1.88738349 |
| 151 | Stomatitis (HP:0010280) | 1.88722305 |
| 152 | Gonadal dysgenesis (HP:0000133) | 1.87305167 |
| 153 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.87126239 |
| 154 | Mitral regurgitation (HP:0001653) | 1.86468677 |
| 155 | Recurrent skin infections (HP:0001581) | 1.86422742 |
| 156 | Osteomalacia (HP:0002749) | 1.86353208 |
| 157 | Fibular hypoplasia (HP:0003038) | 1.85450170 |
| 158 | Hemiplegia (HP:0002301) | 1.84854642 |
| 159 | Abnormality of T cell physiology (HP:0011840) | 1.82933030 |
| 160 | Camptodactyly of toe (HP:0001836) | 1.81879187 |
| 161 | Leukocytosis (HP:0001974) | 1.81747673 |
| 162 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.81437492 |
| 163 | Testicular neoplasm (HP:0010788) | 1.81274704 |
| 164 | Aneurysm (HP:0002617) | 1.81109050 |
| 165 | Abnormality of the hepatic vasculature (HP:0006707) | 1.79989157 |
| 166 | Autoimmune hemolytic anemia (HP:0001890) | 1.79221166 |
| 167 | Chest pain (HP:0100749) | 1.78675171 |
| 168 | Myocardial infarction (HP:0001658) | 1.78271143 |
| 169 | Combined immunodeficiency (HP:0005387) | 1.78045321 |
| 170 | Short hallux (HP:0010109) | 1.77055504 |
| 171 | Focal segmental glomerulosclerosis (HP:0000097) | 1.76385734 |
| 172 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.71268682 |
| 173 | Conical tooth (HP:0000698) | 1.68978322 |
| 174 | Congenital sensorineural hearing impairment (HP:0008527) | 1.68956765 |
| 175 | Xerostomia (HP:0000217) | 1.68612636 |
| 176 | Morphological abnormality of the middle ear (HP:0008609) | 1.68113143 |
| 177 | Genu varum (HP:0002970) | 1.67530459 |
| 178 | Congenital, generalized hypertrichosis (HP:0004540) | 1.66463124 |
| 179 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.65588044 |
| 180 | Anomalous pulmonary venous return (HP:0010772) | 1.65350067 |
| 181 | Abnormality of the renal cortex (HP:0011035) | 1.64447198 |
| 182 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.64105887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.53984857 |
| 2 | STK10 | 2.84405848 |
| 3 | MAP3K10 | 2.60625626 |
| 4 | TGFBR2 | 2.41183969 |
| 5 | ERN1 | 2.41061938 |
| 6 | TXK | 2.26465702 |
| 7 | TAOK3 | 2.22836467 |
| 8 | JAK3 | 2.18935850 |
| 9 | LRRK2 | 2.16245665 |
| 10 | FGFR4 | 2.14599797 |
| 11 | TIE1 | 2.12360441 |
| 12 | TRIB3 | 2.04230075 |
| 13 | FGFR3 | 2.01601798 |
| 14 | MAPK15 | 2.00714780 |
| 15 | JAK1 | 1.99955077 |
| 16 | PIK3CA | 1.95903645 |
| 17 | TBK1 | 1.94615552 |
| 18 | TYK2 | 1.90443231 |
| 19 | ZAP70 | 1.81253753 |
| 20 | KDR | 1.81215739 |
| 21 | ITK | 1.78377499 |
| 22 | GRK6 | 1.77752124 |
| 23 | MAP3K14 | 1.76612078 |
| 24 | TTN | 1.76137287 |
| 25 | SGK2 | 1.71651858 |
| 26 | IKBKE | 1.69455748 |
| 27 | EPHB1 | 1.63641362 |
| 28 | IRAK1 | 1.61725257 |
| 29 | EEF2K | 1.61046398 |
| 30 | CSK | 1.60528529 |
| 31 | WNK4 | 1.58020521 |
| 32 | EPHA3 | 1.57373096 |
| 33 | MST4 | 1.54252814 |
| 34 | TEC | 1.53260247 |
| 35 | RIPK1 | 1.53154999 |
| 36 | AKT3 | 1.44430212 |
| 37 | SGK223 | 1.44287347 |
| 38 | SGK494 | 1.44287347 |
| 39 | BTK | 1.41490514 |
| 40 | PKN2 | 1.41059113 |
| 41 | WNK1 | 1.41001747 |
| 42 | RPS6KA4 | 1.32987378 |
| 43 | STK39 | 1.32185295 |
| 44 | SGK3 | 1.27419132 |
| 45 | HCK | 1.25310748 |
| 46 | KIT | 1.24438871 |
| 47 | PTK6 | 1.17398585 |
| 48 | TGFBR1 | 1.15973201 |
| 49 | NLK | 1.14630629 |
| 50 | BLK | 1.10348963 |
| 51 | CSF1R | 1.10295089 |
| 52 | MARK3 | 1.10111654 |
| 53 | NEK9 | 1.09967176 |
| 54 | ERBB2 | 1.09901481 |
| 55 | FRK | 1.08316468 |
| 56 | CHUK | 1.07955285 |
| 57 | TRPM7 | 1.06956803 |
| 58 | STK38L | 1.06415164 |
| 59 | LCK | 1.04607886 |
| 60 | IKBKB | 1.00842541 |
| 61 | SYK | 1.00480899 |
| 62 | PRKCH | 1.00097884 |
| 63 | FER | 1.00043585 |
| 64 | SIK1 | 0.98722461 |
| 65 | CLK1 | 0.98326956 |
| 66 | BMPR1B | 0.95257055 |
| 67 | EPHB2 | 0.93354806 |
| 68 | PIM1 | 0.92826836 |
| 69 | PTK2B | 0.91331525 |
| 70 | IRAK4 | 0.90304029 |
| 71 | ACVR1B | 0.90110933 |
| 72 | MARK2 | 0.89980336 |
| 73 | CDK12 | 0.88713167 |
| 74 | TYRO3 | 0.87701521 |
| 75 | PRKAA2 | 0.85786270 |
| 76 | DMPK | 0.85577526 |
| 77 | FGFR2 | 0.85255189 |
| 78 | TNK2 | 0.85196465 |
| 79 | CDK9 | 0.84732058 |
| 80 | PAK4 | 0.84347117 |
| 81 | CDK6 | 0.83611065 |
| 82 | MYLK | 0.83566630 |
| 83 | RPS6KA2 | 0.82888767 |
| 84 | MAP2K3 | 0.82632773 |
| 85 | TLK1 | 0.82488470 |
| 86 | ADRBK2 | 0.81330782 |
| 87 | STK38 | 0.80469292 |
| 88 | CDC42BPA | 0.79099388 |
| 89 | MAP3K3 | 0.78971282 |
| 90 | RPS6KA6 | 0.77299860 |
| 91 | NUAK1 | 0.75922997 |
| 92 | MAPK7 | 0.75801120 |
| 93 | PDGFRB | 0.74812489 |
| 94 | MAP3K2 | 0.73318373 |
| 95 | RET | 0.72705782 |
| 96 | MAP3K1 | 0.72364930 |
| 97 | LATS1 | 0.71540651 |
| 98 | PDGFRA | 0.70959997 |
| 99 | CAMK1D | 0.70279869 |
| 100 | JAK2 | 0.70057102 |
| 101 | SIK2 | 0.70022897 |
| 102 | INSRR | 0.69922656 |
| 103 | MELK | 0.69091770 |
| 104 | PDPK1 | 0.68655610 |
| 105 | MATK | 0.67661744 |
| 106 | PRKCQ | 0.66607283 |
| 107 | LYN | 0.66431488 |
| 108 | PINK1 | 0.66216117 |
| 109 | EPHA2 | 0.65813775 |
| 110 | FGFR1 | 0.65199505 |
| 111 | OXSR1 | 0.64797701 |
| 112 | IRAK3 | 0.64137448 |
| 113 | RIPK4 | 0.64049672 |
| 114 | STK3 | 0.63206603 |
| 115 | PAK3 | 0.62318435 |
| 116 | PDK1 | 0.61133307 |
| 117 | STK4 | 0.60963845 |
| 118 | PRKD1 | 0.60289792 |
| 119 | RPS6KC1 | 0.59453936 |
| 120 | RPS6KL1 | 0.59453936 |
| 121 | MAP2K2 | 0.58500167 |
| 122 | SGK1 | 0.56601575 |
| 123 | INSR | 0.56334396 |
| 124 | MAP3K12 | 0.51177671 |
| 125 | YES1 | 0.50831938 |
| 126 | PRKG2 | 0.50617418 |
| 127 | PRKCZ | 0.50493813 |
| 128 | DYRK1B | 0.50344121 |
| 129 | ICK | 0.50230997 |
| 130 | FES | 0.49215258 |
| 131 | PRKD2 | 0.48323381 |
| 132 | ABL1 | 0.48292269 |
| 133 | HIPK2 | 0.48288986 |
| 134 | GRK1 | 0.48078229 |
| 135 | CAMK1G | 0.46928770 |
| 136 | MAP3K8 | 0.46732543 |
| 137 | MAP3K13 | 0.46019291 |
| 138 | EGFR | 0.45486591 |
| 139 | PTK2 | 0.44229400 |
| 140 | MAPKAPK2 | 0.43617816 |
| 141 | CDK4 | 0.43170187 |
| 142 | FGR | 0.42842936 |
| 143 | PAK2 | 0.40674563 |
| 144 | STK24 | 0.40595217 |
| 145 | FYN | 0.39002832 |
| 146 | ILK | 0.38927515 |
| 147 | MAP3K7 | 0.38693182 |
| 148 | BMX | 0.38655301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.39116316 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.95627285 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.59868695 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39023866 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21660479 |
| 6 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.12587168 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04445348 |
| 8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.04322614 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03240481 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00192005 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99554897 |
| 12 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.95706722 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87685514 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.80435782 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.79879763 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79772851 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.69889353 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.67234459 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64943040 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57581896 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56120882 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.55607604 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.52465602 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.51595240 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46672322 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.46003955 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44724707 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44350031 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.42859454 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.42584303 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.41220219 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.40939159 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40593261 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39655061 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.38179205 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36203907 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35554332 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32083932 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31712689 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.31565790 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.29155702 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26790118 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.26394092 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26011413 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25704347 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25357189 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.24715552 |
| 48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.24281853 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23789353 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.22051924 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20823895 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20289637 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19638218 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 1.18103320 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15928508 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15926612 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15835706 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.12949378 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 1.12602877 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 1.12338509 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12222482 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 1.12184791 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11819096 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11241601 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.10791446 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 1.10041410 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.07568512 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04469265 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03994407 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03089319 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01481451 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00020656 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.97675659 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97073098 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.96387459 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.95751723 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94355984 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93857852 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91553057 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86291368 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85395395 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.84535503 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84405052 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84168450 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83215366 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83116562 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82831737 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.82527977 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82448094 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.79612125 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79610313 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.79571807 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.78437132 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77223307 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76816576 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76477353 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75871511 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73932844 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73758492 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72612063 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71484509 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70652120 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70500694 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69478290 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68333462 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67766602 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66964100 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66942411 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66203922 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66063405 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65346450 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65331930 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.64778473 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62999947 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.61573334 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60531189 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60325350 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59614174 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58667223 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58107468 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.56875333 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56218187 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55798186 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53917031 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53748037 |
| 126 | Asthma_Homo sapiens_hsa05310 | 0.53518610 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.53227505 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52069299 |
| 129 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51797323 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50445643 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49767686 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49766464 |
| 133 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49678880 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49547584 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49384718 |
| 136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48444143 |
| 137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48317738 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48188877 |
| 139 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48130654 |
| 140 | Axon guidance_Homo sapiens_hsa04360 | 0.46787319 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46597404 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45522114 |
| 143 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44996215 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44826974 |
| 145 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44209829 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43996740 |
| 147 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43869777 |
| 148 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42024960 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40083540 |

